PRIMARY STUDY
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
Key Findings: Δ9-THCV (a CB1 antagonist) attenuated symptoms and demonstrated neuroprotective effects in an animal models of Parkinson's disease (posited to be initiated via modulation of glutamatergic transmissions.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): Spain
Year of Pub: 2011
Cannabinoids Studied: Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Receptors Studied: CB1
Ligands Studied: Glutamate
